Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV

American Journal of Preventive Medicine

Volumn 44, Issue 1 SUPPL. 2, 2013, Pages

  Campbell, James D ^a   Herbst, Jeffrey H ^b   Koppenhaver, Robert T ^b   Smith, Dawn K ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; PLACEBO; TENOFOVIR DISOPROXIL;

ARTICLE; ATTITUDE; CASE CONTROL STUDY; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FOLLOW UP; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; KNOWLEDGE; MALE HOMOSEXUAL; NAUSEA; OPEN STUDY; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREEXPOSURE PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL BEHAVIOR; SIDE EFFECT; UNITED STATES; VIRUS RESISTANCE;

EID: 84871788385     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2012.09.045     Document Type: Review

References (43)

1. CDC Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men MMWR Morb Mortal Wkly Rep 60 3 2011 65 68
2. CDC Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults MMWR Morb Mortal Wkly Rep 61 31 2012 586 590
3. S.P. Buchbinder, A. Liu Pre-exposure prophylaxis and the promise of combination prevention approaches AIDS Behav 15 S1 2011 S72 S79
4. L. Peterson, D. Taylor, R. Roddy Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial PLoS Clin Trials 2 5 2007 e27
5. R.M. Grant, J.R. Lama, P.L. Anderson Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 27 2010 2587 2599
6. J.M. Baeten, D. Donnell, P. Ndase Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 5 2012 399 410
7. M.C. Thigpen, P.M. Kebaabetswe, L.A. Paxton Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 5 2012 423 434
8. L. Van Damme, A. Corneli, K. Ahmed Preexposure prophylaxis for HIV infection among African women N Engl J Med 367 5 2012 411 422
9. Microbicides Trial Network MTN statement on decision to discontinue use of oral Tenofovir tablets in VOICE, a major HIV prevention study in women www.mtnstopshiv.org/node/3619 2011 sept 28
10. M. Martin, S. Vanichseni, P. Suntharasamai Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand PLoS One 6 9 2011 e25127
11. Grohskopf L GR, Pathak S, et al. Preliminary analysis of biomedical data from the phase II clinical safety trial of tenofovir disoproxil fumarate (TDF) for HIV-1 pre-exposure prophylaxis (PrEP) among U.S. men who have sex with men (MSM). In: 18th International AIDS Conference. Vienna, Austria; 2010.
12. AVAC: Global Advocacy for HIV Prevention Ongoing and planned pre-exposure prophylaxis (PrEP) trials www.avac.org/ht/a/GetDocumentAction/i/3113 April 2012
13. J.B. DeLuca, M.M. Mullins, C.M. Lyles, N. Crepaz, L. Kay, S. Thadiparthi Developing a comprehensive search strategy for evidence-based systematic review Evid Based Libr Information Pract 3 2008 3 32
14. E.A. Barash, M. Golden Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic AIDS Patient Care STDs 24 11 2010 689 691
15. R.A. Brooks, R.L. Kaplan, E. Lieber, R.J. Landovitz, S.J. Lee, A.A. Leibowitz Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships AIDS Care 23 9 2011 1136 1145
16. R.A. Brooks, R.J. Landovitz, R.L. Kaplan, E. Lieber, S.J. Lee, T.W. Barkley Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study AIDS Patient Care STDs 26 2 2012 87 94
17. S.A. Golub, W. Kowalczyk, C.L. Weinberger, J.T. Parsons Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men J Acquir Immune Defic Syndr 54 5 2010 548 555
18. B.A. Koblin, C. Murrill, G. Xu Awareness of HIV prevention strategies under development: word on the street J Acquir Immune Defic Syndr 48 2 2008 232 234
19. A.Y. Liu, P.V. Kittredge, E. Vittinghoff Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men J Acquir Immune Defic Syndr 47 2 2008 241 247
20. G. Mansergh, B.A. Koblin, G.N. Colfax, D.J. McKirnan, S.A. Flores, S.M. Hudson Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among U.S. men who have sex with men J Acquir Immune Defic Syndr 55 2 2010 e14 e16
21. S.A. Mehta, R. Silvera, K. Bernstein, R.S. Holzman, J.A. Aberg, D.C. Daskalakis Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City Sex Transm Infect 87 4 2011 344 348
22. M.J. Mimiaga, P. Case, C.V. Johnson, S.A. Safren, K.H. Mayer Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education J Acquir Immune Defic Syndr 50 1 2009 77 83
23. N. Nodin, A. Carballo-Dieguez, A.M. Ventuneac, I.C. Balan, R. Remien Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback AIDS Care 20 1 2008 106 115
24. A.C. Voetsch, J.D. Heffelfinger, E.B. Begley, K. Jafa-Bhushan, P.S. Sullivan Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006 J Acquir Immune Defic Syndr 46 3 2007 378 380
25. Al-Tayyib A, Voetch A, Thrun M, et al. Knowledge of and attitudes towards pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men, 2008. Proceedings of the National HIV Prevention Conference; 2009; Atlanta GA.
26. D.S. Krakower, M.J. Mimiaga, J.G. Rosenberger Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site PLoS One 7 3 2012 e33119
27. S.E. Kellerman, A.B. Hutchinson, E.B. Begley, B.C. Boyett, H.A. Clark, P. Sullivan Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004 J Acquir Immune Defic Syndr 43 3 2006 376 377
28. Bautista G, Todd J, Carney J, DeQuezada A, Drenzek C. Awareness of the existence of pre- and post-exposure prophylaxis for HIV prevention among MSM in metro Atlanta: findings of the Georgia HIV Behavioral Surveillance (GHBS) system. Proceedings of the Georgia Public Health Association Annual Conference; 2012; Atlanta GA.
29. Y.O. Whiteside, T. Harris, C. Scanlon, S. Clarkson, W. Duffus Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina AIDS Patient Care STDs 25 6 2011 365 370
30. T. Khawcharoenporn, S. Kendrick, K. Smith HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic AIDS Patient Care STDs 26 4 2012 222 233
31. E.A. Arnold, P. Hazelton, T. Lane A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection PLoS One 7 7 2012 e40603
32. A. Tripathi, C. Ogbuanu, M. Monger, J.J. Gibson, W.A. Duffus Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern U.S. South Med J 105 4 2012 199 206
33. J.M. White, M.J. Mimiaga, D.S. Krakower, K.H. Mayer Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention AIDS Patient Care STDs 26 7 2012 395 405
34. K. Underhill, D. Operario, M. Skeer, M. Mimiaga, K. Mayer Packaging PrEP to Prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice J Acquir Immune Defic Syndr 55 1 2010 8 13
35. D.K. Smith, L. Toledo, D.J. Smith, M.A. Adams, R. Rothenberg Attitudes and program preferences of African American urban young adults about pre-exposure prophylaxis (PrEP) AIDS Educ Prev 24 5 2012 408 421
36. L.A. Paxton, T. Hope, H.W. Jaffe Pre-exposure prophylaxis for HIV infection: what if it works? Lancet 370 9581 2007 89 93
37. K.A. Gebo, J.A. Fleishman, R. Conviser Contemporary costs of HIV healthcare in the HAART era AIDS 24 17 2010 2705 2715
38. K. Desai, S.L. Sansom, M.L. Ackers Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the U.S.: HIV infections prevented and cost-effectiveness AIDS 22 14 2008 1829 1839
39. A.D. Paltiel, K.A. Freedberg, C.A. Scott HIV preexposure prophylaxis in the U.S.: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness Clin Infect Dis 48 6 2009 806 815
40. R.T. Koppenhaver, S.W. Sorensen, P.G. Farnham, S.L. Sansom The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the U.S.: an epidemic model J Acquir Immune Defic Syndr 58 2 2011 e51 e52
41. J.L. Juusola, M.L. Brandeau, D.K. Owens, E. Bendavid The cost-effectiveness of preexposure prophylaxis for HIV prevention in the U.S. in men who have sex with men Ann Intern Med 156 2012 541 550
42. S.F. Morin, G. Yamey, G.W. Rutherford HIV pre-exposure prophylaxis BMJ 345 2012 e5412
43. J.H. Herbst, M. Glassman, J.W. Carey Operational research to improve HIV prevention in the U.S. J Acquir Immune Defic Syndr 59 2012 530 536